Tag: Safety

FDA designates Class I recall for neurosurgery software

Editor's Note The US Food & Drug Administration (FDA) has classified Medtronic’s recall of its StealthStation S8 software as a Class I, the most severe category indicating risk of serious injury or death. The StealthStation System with StealthStation Cranial software is intended as an aid for locating anatomical structures during…

Read More

By: Matt Danford
June 5, 2024
Share

Hospital margins, ED visits up, length of stay down in April, Kaufman report reveals

Editor's Note The median hospital margin of 3.8% for April is an improvement over the previous month and year-over-year, according to the latest National Hospital Flash Report from Kaufman Hall. Compiled by Kaufman and Syntellis Performance Solutions (now part of Strata), the monthly report analyzes 3 years’ worth of both…

Read More

By: Matt Danford
June 4, 2024
Share

Dialysis patients feasible for kidney donation, transplant outcome study suggests

Editor's Note A retrospective cohort study found transplanting kidneys from donors who underwent dialysis resulted in no long-term differences in graft failure, kidney function, or death, but recipients had significantly higher risk for delayed graft function (DGF). According to a May 23 MedPage Today report on the study, originally published…

Read More

By: Matt Danford
June 3, 2024
Share

HHS: Change Healthcare responsible for cyberattack data breach notifications

Editor's Note Change Healthcare is responsible for notifying affected parties about privacy breaches resulting from the February cyberattack on the company, The U.S. Department of Health and Human Services (HHS) announced May 31. The announcement took the form of an update to an FAQ webpage from HHS’ Office for Civil…

Read More

By: Matt Danford
June 3, 2024
Share

Class 1 recall announced for ambulatory infusion pump

Editor's Note The US Food and Drug Administration (FDA) has designated OptumHealth Care Solutions’ recall of the Nimbus II ambulatory infusion pumps a class 1, the most severe category indicating risk of serious injury or death. According to the agency’s May 30 announcement, the company recalled the pumps in direct…

Read More

By: Matt Danford
May 31, 2024
Share

Surgery benefits transplant-ineligible HCC patients more than less invasive options

Editor's Note Liver resection provides a significant survival benefit over percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE) in patients with early multinodular hepatocellular carcinoma (HCC), according to findings published May 15 in JAMA Surgery. Thus, liver resection should be considered the first therapeutic option in patients with early multinodular…

Read More

By: Matt Danford
May 29, 2024
Share

Colorado passes first state-level AI regulations

Editor's Note Colorado is the first state in naton to pass legislation regulating the use of artificial intelligence (AI) in pivotal decision-making, including in healthcare, according to a May 22 report in Politico. The new law has sparked significant debate, according to the report, with some viewing it as a…

Read More

By: Matt Danford
May 29, 2024
Share

Study: Infection risk unaffected by colonoscopy, joint replacement timing

JAMA (healthcare publication) Network logo

Editor's Note A study published May 7 in JAMA Open found no significant risk of periprosthetic joint infection (PJI) when colonoscopy is performed within one year of total joint arthroplasty (TJA), whether the colonoscopy was done before or after the surgery. However, certain comorbidities such as kidney and pulmonary disease,…

Read More

By: Matt Danford
May 28, 2024
Share

Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

By: Matt Danford
May 28, 2024
Share

Colon cancer study: Robots harvest more lymph nodes than conventional laparoscopic surgery (CLS)

Editor's Note Although robotic-assisted laparoscopic surgery (RLS) and conventional laparoscopic surgery (CLS) offer similar survival outcomes for sigmoid colon cancer, RLS harvests comparatively more lymph nodes, according to a study published May 10 in the Journal of Robotic Surgery. According to a May 15 report on the study in The…

Read More

By: Matt Danford
May 24, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat